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INTRODUCTION 
Primary Aldosteronism (PA) is a condition 
characterized by excessive aldosterone secretion which 
leads to hypertension and an overall higher risk of 
mortality from cardiovascular diseases [1]. Conn’s 
syndrome specifically refers to PA secondary to an 
adrenal adenoma which is also referred to as 
Aldosterone-producing adenomas (APA) [2]. The other 
subtypes of PA include Idiopathic Adrenal Hyperplasia 
(IAH) which can be unilateral or bilateral, familial 
hyperaldosteronism (FH) and more rarely ectopic 
aldosterone secretion from neoplastic disease [3]. The 
subtypes of PA are an important determining factor for 
effective management of patients. Unilateral disease is 
potentially curable with surgery while bilateral disease 
is treated medically with mineralocorticoid receptor 
(MR) antagonist. Surgical  
 
removal of APA leads to improved cardiovascular 
outcomes, improvement in hypertension in almost all 
cases and normalization of potassium level [4]. An 
important caveat is that the presence of an adrenal 
adenoma or nodule does not always indicate 
hypersecretion of aldosterone from the particular 
growth. Non-functioning adrenal adenomas are a 
common occurrence especially in older patients [5]. 
Hypersecretion of aldosterone can be confirmed with a 
procedure called Adrenal Vein Sampling (AVS). There 
is known discordance between adrenal imaging with 
computed tomography (CT) and AVS and the rate is 
approximately 20-28% [6]. We, therefore, present a 
case in which such discordance was observed and 
fortunately the patient was managed appropriately in a 
tertiary centre with available facilities. 
ABSTRACT 
 
Primary aldosteronism (PA) causes a persistently elevated blood pressure (BP) due to 
excessive release of the hormone aldosterone from the adrenal glands. Classically, it is called 
Conn’s syndrome and is described as the triad of hypertension and hypokalemia with the 
presence of unilateral adrenal adenoma. It can be cured with surgical resection of the 
aldosterone-secreting adenoma leading to resolution of hypertension, hypokalemia and 
increased cardiovascular risk associated with hyperaldosteronism. We present a case of a man 
with previous ischemic heart disease (IHD) who presented with resistant hypertension. 
Investigations for secondary causes of hypertension revealed an elevated aldosterone level 
and saline suppression test confirmed the diagnosis of PA. Radiological examination revealed 
a left adrenal adenoma and a normal right adrenal gland. However, adrenal venous sampling 
showed lateralization of aldosterone secretion towards the right. He subsequently underwent 
a laparoscopic right adrenalectomy which improved his BP control promptly. This case 
highlights the importance of recognizing the need to investigate for secondary causes of 
hypertension. It also underscores the importance of dynamic tests, which may not be easily 
accessible to most clinicians but should pursue, to allow a definitive diagnosis and effective 
treatment. 
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CASE PRESENTATION 
A 61-year-old man was referred to Emergency 
Department (ED) with hypertensive urgency. His blood 
pressure (BP) was 212/112 mmHg on presentation and 
remained high on consecutive measurements. He 
denied symptoms of headache, visual disturbance or 
any neurological deficit. He had been diagnosed with 
essential hypertension about 5 years prior and his BP 
had never been optimally controlled. He had stopped 
taking all his medications which included 2 types of 
anti-hypertensives in the last 2 years as he had felt well. 
Other medical problems included a previous history of 
myocardial infarction requiring angioplasty and 
stenting 4 years prior, hyperlipidemia and chronic 
kidney disease (CKD) stage IIIB. There was no 
previous history of admission to hospital for 
hypertension related morbidities. 
 Initial investigations showed serum creatinine 
of 118µmol/L (NR 62-96) and normal potassium level 
of 4.5 mmol/L (NR 3.5-5.0). Hemoglobin was 13.8g/dL 
(NR 12-16) and thyroid function test was normal. There 
was elevated total cholesterol of 6.8 mmol/L (NR <5.2) 
and LDL-cholesterol of 5.0mmol/L (NR<2.6). 
Electrocardiography (ECG) showed normal sinus 
rhythm with a rate of 80 beats per minute. There were 
high voltage QRS complexes, ST depression and T-
wave inversions in the inferior leads consistent with 
long standing hypertension and previous history of MI. 
Echocardiogram showed left ventricular hypertrophy 
and dilated left ventricle with reduced left ventricular 
ejection fraction (LVEF) of 46%. He was admitted for 
a total of 9 days and discharged with a total of 5 anti-
hypertensive medications, including Indapamide, 
Telmisartan, Carvedilol, Felodipine, and 
Spironolactone. 
 
Figure 1 Contrast enhanced Computed Tomography study of the abdomen in axial views; (A) of the right adrenal gland and (B) of the left adrenal 
gland (in red box) with its corresponding magnified images. The right adrenal gland, despite bulky, is normal in appearance. There is a non-
enhancing hypodense nodule with foci of calcification within arising from the left adrenal gland. 
 He was subsequently referred to the Endocrine 
Unit for further investigations for secondary causes of 
hypertension. Doppler ultrasound of the kidneys 
revealed no evidence of suprarenal mass or renal artery 
stenosis and both kidneys were of normal size. 24-hour 
urinary cortisol level was normal at 719.6nmol/day 
(NR: 53.2 – 876.3) as well as 24-hour urinary 
catecholamine levels. Urinary epinephrine was 1.8 
µg/day (NR: 0.5 – 20), urinary norepinephrine of 
36.7µg/day (NR: 15 – 80) and urinary dopamine level 
was 143 µg/day (NR: 64 – 400). His anti-hypertensive 
medications were ceased and replaced by high doses of 
prazosin and felodipine. Subsequent investigations  
demonstrated an elevated serum aldosterone of 924 
pmol/L (NR: 111 – 860) with suppressed plasma renin 
activity of 0.4ng/ml/hr (NR: 1.5 – 5.7) with an 
aldosterone to renin ratio of 2060 (NR <750). A Saline 
Suppression Test (SST) was performed with the 
administration of one litre of intravenous saline over 4 
hours. The results were as follows: pre-saline 
aldosterone level of 995 pmol/L (NR: 111 – 860); post-
saline aldosterone of 511 pmol/L (NR < 140). A non-
contrasted computed tomography (CT) of the adrenal 
glands revealed a left adrenal adenoma measuring 
1.4cm x 1.5cm with a Hounsfield Unit (HU) of 12 and 
absolute washout of 60% (Figure 1). The right adrenal 
The Invisible Twin of an Adrenal Adenoma 
 
 
Vol 4(1) (2019) 58-63 | jchs-medicine.uitm.edu.my | eISSN 0127-984X 
 
60 
gland was slightly bulky, but normal in appearance with 
no focal lesion within. Surgical resection of the adrenal 
adenoma as a potential treatment option was discussed 
and patient was keen to proceed. 
 Adrenal venous sampling (AVS) was later 
performed by an interventional radiologist with 
cosyntropin stimulation [7]. The procedure involved 
cannulation of the inferior vena cava (IVC) initially and 
then sequentially both right and left adrenal veins. 
Measurement of both cortisol and aldosterone level are 
performed with each cannulation. The ratio between 
cortisol levels between each adrenal vein (left and right) 
and IVC confirms the accuracy of cannulation into the 
adrenal veins. This is called Cannulation Index (CI) and 
a CI of 2-3 is adequate. The ratio of aldosterone and 
cortisol levels (AC ratio) between the two adrenal veins 
gives the lateralisation index (LI) which proves which 
adrenal gland is hypersecreting aldosterone. A ratio of 
3-5 is considered adequate to prove lateralisation [7]. 
 The results of the AVS showed a CI of 15 for 
the right side and 23 for the left indicating adequate 
cannulation. There is a LI ratio of 8.6 towards the right 
adrenal gland which is significant at 8:1 (Table 1). The 
patient subsequently underwent a repeat AVS to 
ascertain the findings, which produced similar results.  
 
 
Table 1 Results of Adrenal Vein Sampling 
Vein Aldosterone 
(A), pmol/L 
Cortisol 
(C), 
nmol/L 
A/C 
ratio 
LI 
ratio 
Right 
Adrenal 
Vein 
90,265 8684 10.4 8.6 
Left 
Adrenal 
Vein 
15,848 13,699 1.2  
Inferior 
Vena 
Cava 
1,674 591 2.8  
 He underwent a successful laparoscopic right 
adrenalectomy one month subsequent to the AVS 
results and recovered well. Gross examination of the 
excised adrenal gland (measuring 45x22x10 mm) 
revealed a single, well defined yellowish nodule 
(10x7x5 mm) located on one side of the gland. 
Microscopically, this nodule was encased in a thin, 
delicate capsule; it contained cells with round nucleus 
surrounded by foamy cytoplasm mixed with lesser 
number of cells with eosinophilic cytoplasm. Mitosis 
and atypia were absent. The rest of the gland showed 
normal histology. The overall histological features are 
in keeping with an adrenal cortical adenoma (Figure 2). 
 Subsequent clinic visits post-surgery revealed 
stable BP control. He is currently well, requiring only 
low doses of 2 anti-hypertensive agents which are 
carvedilol and felodipine.
 
Figure 2 (a) Gross examination of the adrenal gland revealed a well-defined nodule on one side of the gland (black arrow), the rest of the adrenal 
cortex was normal, with no evidence of hyperplasia (red arrow). (b)Photomicrograph of showed a well circumscribed nodule (arrow) surrounded 
by a thin rim of fibrous tissue (Haematoxylin and Eosin (H&E), magnification 40X); (c) the cells within the nodules are composed polygonal cells 
with round nucleus and foamy cytoplasm (H&E, magnification 400X); (d) the rest of the adrenal gland show normal morphology (H&E, 
magnification 40X). 
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DISCUSSION 
This case firstly highlights the importance of 
identifying the rarer condition of hyperaldosteronism in 
a seemingly common disease of hypertension. There 
should be a high degree of suspicion for secondary 
causes of hypertension in patients with resistant blood 
pressure controls. Clinicians should be vigilant of 
patients requiring 3 or more anti-hypertensive 
medications as this indicates resistant hypertension. A 
previous diagnosis of essential hypertension should not 
deter clinicians from conducting further investigations 
to rule out both structural or hormonal abnormalities. 
However, it is imperative to rule out pseudoresistance 
factors such as white coat hypertension, non-
compliance to medications and inaccurate blood 
pressure measurement [8]. 
 Resistant hypertension has a myriad of 
causative factors. Structural abnormalities such as renal 
artery stenosis (RAS) and coarctation of the aorta may 
be present and easily diagnosed with imaging 
techniques such as doppler ultrasonography and 
computed tomographic angiography (CTA) 
respectively [9]. Only 10% of RAS cases are derived 
from fibromuscular dysplasia which classically affects 
females less than 50 years of age [10]. RAS occurs most 
commonly in the elderly populations especially 
smokers and those with pre-existing atherosclerotic 
disease. This is especially relevant as it fits the 
demographics of this case and therefore has been 
adequately assessed. 
 Hormonal abnormalities resulting in resistant 
hypertension can be due to PA, phaeochromocytoma, or 
Cushing’s syndrome. All of the three aforementioned 
conditions are associated with hypersecretion from an 
adrenal adenoma and is particularly relevant in this 
case. An adrenal adenoma can be present and be a non-
functioning nodule and this is termed adrenal 
incidentiloma. It is a common occurrence in the older 
age group of >40 years of age and is usually identified 
during imaging that is performed for indications not 
related to investigation of resistant hypertension. 
Biochemical investigations to screen for hormonal 
excess causing resistant hypertension are crucial to 
determining the diagnosis and excluding adrenal 
incidentilomas. 
 Phaeochromocytoma is a rare disease with a 
prevalence of <1% of the hypertensive population. Its 
clinical manifestation include episodic symptoms of 
headache, palpitations and sweating with concomitant 
resistant hypertension [11]. A highly sensitive test for 
screening is 24-hour urinary metanephrines or plasma 
free metanephrines [12]. As for Cushing’s syndrome, 
screening involves either a 24-hour urinary free cortisol, 
late-night salivary cortisol or 1-mg overnight 
dexamethasone suppression test [13]. Hypercortisolism 
from Cushing’s syndrome results in specific clinical 
features such as central obesity, moon face, easy skin 
bruising, purple striae and proximal muscle weakness. 
Hypertension is a major component of Cushing’s 
syndrome and it is due to water retention and volume 
expansion related to excess cortisol [14].  
 PA is the commonest hormonal abnormality 
resulting in resistant hypertension. The estimated 
prevalence of PA in hypertensive population is between 
5% to 13% [15]. According to the 2016 Endocrine 
Society Clinical Guideline for the diagnosis of PA, all 
patients with hypertension requiring 3 or more anti-
hypertensive medications should be screened for PA 
[15]. Other indications include hypertension 
accompanied by sleep apnea, presence of family history 
of premature IHD or stroke (<40years) and with known 
first-degree relative with PA [15]. The same clinical 
guideline also clearly outlines the necessary processes 
for diagnosis and management of PA.  
 Initial screening test is done with serum 
aldosterone paired with direct renin level. In order to 
achieve a useful result, several anti-hypertensive 
medications need to be discontinued. These 
medications can cause false positive or false negative 
results. The medications are ACE-Inhibitors, 
Angiotensin-Receptor Antagonist, Beta-blockers, 
Mineralocorticoid Receptor Blockers and Diuretics 
[15]. A positive screening test would be an elevated 
aldosterone level and low renin, with an aldosterone to 
renin ratio of >750. Confirmatory tests are mandatory 
after a positive screening test. A commonly used test is 
the saline suppression test which would show failure of 
aldosterone suppression with salt loading. This 
establishes the diagnosis of PA. 
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 The decision to screen for PA can be influenced 
by other supporting factors such as age and presence of 
hypokalemia. International guidelines have outlined the 
need for screening for secondary causes of hypertension 
among younger patients below the age of 40. This case 
not only affirms that statement but also emphasizes that 
decisions to screen patients should be based on 
individual needs and not restrict to only those below 40 
years of age. Also, the presence of hypokalemia is a 
strong predictor for PA but it is only present in severe 
disease. Despite previous understandings of 
hyperaldosteronism, more recent data have indicated 
that hypokalemia only occurs in 9 to 37% of patients 
with confirmed PA [15]. Thus, the majority of patients 
with PA may have normal potassium levels as 
demonstrated in this case. The normal potassium level 
may have delayed the detectability of the underlying 
condition. However, this should no longer be an 
exclusion to proceed with further investigations for PA. 
Early detection and treatment of PA is pivotal in 
cardiovascular risk reductions such as stroke and IHD 
[16]. 
 After establishing the diagnosis of PA, the next 
step is to determine the disease subtype. This is crucial 
as the different subtypes of PA have distinct treatment 
options. The process of subtyping is by imaging with 
CT scan to assess for the presence of adrenal adenoma. 
The presence of adrenal adenoma; either unilateral or 
bilateral as well as the patient’s preference for surgical 
intervention determines subsequent management 
options. If surgical intervention is not desired in 
unilateral disease or there are bilateral adenomas, 
medical treatment with MR antagonist is commenced. 
 In unilateral adrenal adenoma with surgery as a 
treatment option, lateralization is done with AVS [15]. 
AVS is used to localize and lateralize aldosterone 
hypersecretion. It is a highly specific procedure and 
requires high technical expertise albeit with varying 
success rates, thus rendering it not widely available 
[17]. Once lateralization is confirmed and consistent 
with the presence of an adenoma, surgery can proceed 
and patient can potentially be cured. 
 The most significant impact of this report is the 
benefit and necessity of AVS towards achieving the best 
treatment option for this patient. AVS is recommended 
for lateralization as the accuracy of imaging is only 
about 50% [18]. This is partly attributed to the rise in 
adrenal incidentilomas especially in older populations. 
This discordance between imaging with CT and AVS in 
lateralization of PA is well documented. A recent study 
showed the discordance rate was 20-28% and related to 
both imaging and AVS factors [6]. The discordance can 
be attributed to operator-dependant expertise in AVS 
techniques and also variable interpretation criteria. The 
adequacy of AVS is important to address as it is a factor 
in the discordance between imaging and AVS [6]. The 
accuracy of AVS can be improved by a repeat 
procedure, ensuring adequate cannulation of the adrenal 
veins and also using a less stringent LI ratio during 
interpretation [6]. Thus, this case emphasizes a 
pertinent issue of providing the most effective 
management. The patient could have had an 
inappropriate removal of the left adrenal incidentaloma, 
had the AVS not been or inadequately performed. That 
would have resulted in a futile surgery and he would 
have consequently required a second adrenalectomy on 
the contralateral side, leaving him with absolute 
hypocortisolism and requiring life-long hydrocortisone 
replacement. 
CONCLUSION 
In conclusion, identification of resistant hypertension is 
essential in order to identify secondary causes of 
hypertension. Hormonal causes to be considered are 
PA, phaeochromocytoma and Cushing’s syndrome 
especially in the presence of an adrenal adenoma. The 
diagnosis of PA requires a high degree of clinical 
suspicion and should be prioritized to individual 
patients. Early detection and treatment may confer 
significant benefits. Age below 40 and presence of 
hypokalemia are no longer absolute requirements for 
screening for PA. Screening for PA should be done in 
patients who have resistant hypertension requiring more 
than three anti-hypertensive medications. Upon 
confirmation of hyperaldosteronism, radiological 
imaging is indicated but not limited. Adrenal venous 
sampling, if indicated, must be pursued to ensure 
accurate lateralization and subsequent effective surgical 
treatment.  
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